SCHEMBL13623260

SCHEMBL13623260

c1ccc(N2c3ccccc3CCc3cc(-c4ccc(-c5ccc6c(c5)CCc5ccccc5N6c5ccccc5)c5ccccc45)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.41
CYP11B1 P15538 7/20 0.39
CYP11B2 P19099 7/20 0.39
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
HSD17B3 P37058 3/20 0.38
GAA P10253 3/20 0.35
GFER P55789 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
SRD5A1 P18405 1/20 0.34
PKM P14618 1/20 0.33
TLR9 Q9NR96 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MCL1 Q07820 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CES2 O00748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623258 0.88 HPGD (0.41) HPGDCYP11B1CYP11B2ADRA2AADRA2B
SCHEMBL13623253 0.87 HSD17B3 (0.48) HPGDCYP11B1CYP11B2ADRA2AADRA2B
SCHEMBL13623257 0.85 ALDH1A1 (0.47) HPGDCYP11B1CYP11B2HSD17B3ALDH1A1
SCHEMBL13158706 0.80 HSD17B3 (0.41) HPGDCYP11B1CYP11B2ADRA2AADRA2B
SCHEMBL14281334 0.80 HPGD (0.59) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL13408731 0.79 HPGD (0.37) HPGDCYP11B1CYP11B2ADRA2AADRA2B
SCHEMBL13899986 0.78 CYP11B1 (0.38) HPGDCYP11B1CYP11B2ADRA2AADRA2B
SCHEMBL14155275 0.76 HPGD (0.45) HPGDADRA2AADRA2BADRA2CGAA
SCHEMBL2208353 0.76 HPGD (0.46) HPGDADRA2AADRA2BADRA2CHSD17B3
SCHEMBL6123811 0.76 HPGD (0.56) HPGDADRA2AADRA2BADRA2CHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R HPGD 3468/4885CYP11B1 910/4885CYP11B2 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.